Literature DB >> 9175210

The release of gastric inhibitory peptide, glucagon-like peptide-I, and insulin after oral glucose test in colectomized subjects.

C Palnaes Hansen1, J J Andreasen, J J Holst.   

Abstract

BACKGROUND: The physiologic role of the colon as an endocrine organ is not clear. We therefore studied the enteroinsular axis in patients with ulcerative colitis after colectomy.
METHODS: The subjects included 11 patients with a conventional ileostomy, 10 patients with an ileoanal reservoir, and 10 normal controls. The concentrations of glucose, insulin, gastric inhibitory peptide (GIP), and glucagon-like peptide-I (GLP-I) were measured in plasma during an oral glucose test.
RESULTS: The peak level of glucose and peak levels and area under the curve (AUC) of insulin and GIP were higher in patients (P < 0.05). Neither the peak level nor the AUC of GLP-I differed between patients and controls, but time to peak level was four times longer in patients with an ileoanal reservoir (P < 0.05).
CONCLUSION: Colectomy seems to affect the enteroinsular axis, leading to hyperinsulinemia and an impaired glucose tolerance. Moreover, patients with an ileoanal reservoir have a slower GLP-I response after intake of glucose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175210     DOI: 10.3109/00365529709025084

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Gastric emptying rate of solids is reduced in a group of ileostomy patients.

Authors:  M D Robertson; J C Mathers
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 2.  Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.

Authors:  Hubert Zatorski; Maciej Sałaga; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-29       Impact factor: 3.000

Review 3.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

Review 4.  Role of Incretin Axis in Inflammatory Bowel Disease.

Authors:  Lihua Duan; Xiaoquan Rao; Zachary Braunstein; Amelia C Toomey; Jixin Zhong
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

Review 5.  Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.

Authors:  Andrea Verdugo-Meza; Jiayu Ye; Hansika Dadlani; Sanjoy Ghosh; Deanna L Gibson
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

6.  The long term microbiota and metabolic status in patients with colorectal cancer after curative colon surgery.

Authors:  Xi-Hsuan Lin; Jeng-Kai Jiang; Jiing-Chyuan Luo; Chung-Chi Lin; Po-Hsiang Ting; Ueng-Cheng Yang; Yuan-Tzu Lan; Yi-Hsiang Huang; Ming-Chih Hou; Fa-Yauh Lee
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

7.  Colonic inflammation induces changes in glucose levels through modulation of incretin system.

Authors:  Hubert Zatorski; Maciej Salaga; Marta Zielińska; Anna Mokrowiecka; Damian Jacenik; Wanda Małgorzata Krajewska; Ewa Małecka-Panas; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2021-09-17       Impact factor: 3.024

Review 8.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

9.  Increase in clinically recorded type 2 diabetes after colectomy.

Authors:  Anders B Jensen; Thorkild Ia Sørensen; Søren Brunak; Kristine H Allin; Oluf Pedersen; Tine Jess
Journal:  Elife       Date:  2018-10-30       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.